Preoperative risk factors, intraoperative fluid shifts, and transfusions place patients at increased risk for right ventricular failure during left ventricular assist device implantation. Despite aggressive use of inotropes and pulmonary vasodilators, in severe cases of RV failure, a right ventricular assist device may be required. For the past several years, we have been implanting right ventricular assist devices in the presented configuration, allowing less invasive removal without sternotomy. The method is presented herein.
MangiA.A.Right ventricular dysfunction in patients undergoing left ventricular assist device implantation: predictors, management, and device utilization. Cardiol Clin.2011; 29: 629–637.
2.
LazarJ.F., SchiralliM., PisulaB.Does treating acute cardiogenic shock with biventricular assist devices improve survival: a single institution review. ASAIO Cardiac Abstracts ASAIO J.2012; 58: 20–45.
3.
LazarJ.F., SwartzM.F., SchiralliM.P.Survival after left ventricular assist device with and without temporary right ventricular support. Ann Thorac Surg.2013; 96: 2155–2159.
4.
TchantchaleishviliV., StaicuS.A., GiampoliE.J., ChenL., MasseyH.T.Utilizing right ventricular assist device with extracorporeal membrane oxygenator for management of diffuse alveolar damage after orthotopic heart transplant. Artif Organs.2015; 39: 289–291.
5.
TchantchaleishviliV., HallinanW., SchwarzK.Q., MasseyH.T.Long-term total cardiac support in a Fontan-type circulation with HeartMate II left ventricular assist device. Interact Cardiovasc Thorac Surg.2016; 22: 692–694.
